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A young female presented with BuddeChiari syndrome due to membranous obstruction of
inferior vena cava. Membrane was quite thick with complete occlusion of the IVC. She had
a previous unsuccessful attempt at endovascular stenting using conventional CTO wire
technique. She was successfully treated with balloon angioplasty and stenting after
perforation of the thick membrane with Brokenborough’s needle. At three months follow-
up she was asymptomatic with patent stent.
Copyright ª 2014, Cardiological Society of India. All rights reserved.1. Case report
A previously healthy 41-year-old female was referred to our
center with 2 months history of abdominal pain, abdominal
distention, pedal edema and loss of appetite. There was no
history of jaundice. She was diagnosed to have hypothyroid-
ism two years back andwas on thyroid hormone replacement.
Clinical examination revealed markedly distended abdomen
with prominent superficial veins and bilateral pedal edema.
There was no jaundice and JVP was not elevated. Vitals were
stable. Laboratory examination at another hospital revealed a
total bilirubin of 1.6 mg/dl and mildly raised liver enzymes.
Ultrasound of abdomen showed moderate ascites, hepato-
megaly and complete occlusion of proximal inferior vena cava
(IVC). Endoscopy revealed oesophageal varices. Contrasta Residency, Hill Fort Roa
. Poddar).
ociety of India. All rightsenhanced computed tomography was done which revealed a
thick web in proximal IVC with complete occlusion (Fig. 1).
Patient was referred to us for PTA and stenting of IVC after a
failed attempt at another hospital. Patient was already on oral
anticoagulation for the last 6 weeks at the time of presenta-
tion at our center.
Patient was primed with 300 mg of Clopidogrel and 325 mg
of Aspirin. Venous access was obtained via 6 Fr sheaths in
right Internal Jugular Vein (IJV) and right Femoral Vein (FV).
Unfractionated heparin (5000 units) was given. Venography
was performed by simultaneous contrast injections via NIH
catheter in right IJV and pigtail catheter in right FV in two
orthogonal views. It revealed a short completely occluded
segment (thick web) in proximal IVC with post stenotic dila-
tation (Fig. 2). The thick web was punctured with a Broken-
borough’s needle. After confirming the position ofd, Nowbat Pahad, Hyderabad 500 004, India.
reserved.
Fig. 1 e Contrast enhanced CT of the abdomen showing
complete occlusion of proximal IVC (arrows).
Fig. 3 e Dilatation of proximal IVC with 12 3 40 mm
balloon.
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was advanced over the needle into the IVC beyond the oc-
clusion. Then a 0.03200 J-tip wirewas negotiated across theweb
and was parked in right subclavian vein via superior vena
cava. The web was first dilated with septal dilator over the
0.03200 wire and then sequentially with 6  15 mm and
12  40 mm balloons (Fig. 3). Proximal IVC was then stented
with 22  45 mm self-expanding wall stent. IVC venogramFig. 2 e IVC venogram showing a thick membrane in
proximal IVC causing complete occlusion.post stenting showed good stent apposition with brisk flow
(Fig. 4). Distended superficial abdominal veins disappeared on
table itself. Patient was ambulated the following day and she
had marked reduction in abdominal girth. She was given
unfractionated heparin for 2 days and was discharged on oral
anticoagulation on 3rd post-procedure day. Patient was
asymptomatic at 3 months follow up and venous Doppler
revealed patent IVC stent.Fig. 4 e Venogram showing restoration of IVC patency after
deployment of 22 3 45 mm self-expanding wall stent.
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BuddeChiari syndrome is defined as hepatic venous outflow
track obstruction at any level from small hepatic veins to right
atrium-IVC junction, regardless of the cause of obstruction.1,2
Pure IVC obstruction is more common in Asia whereas pure
hepatic vein obstruction predominates in Western countries.3
Most common cause of IVC obstruction is by membranous
web. Membranous webs were earlier thought to be of
congenital origin, but more recent evidence suggests that
membranouswebsare the sequelaeof thrombus formation.4e6
Treatment of BCS varies depending on the etiology, pre-
sentation and the level of obstruction. It includes thrombol-
ysis, surgical porto-systemic shunts, transjugular intrahepatic
porto-systemic shunt (TIPS), endovascular PTA and liver
transplantation. Endovascular angioplasty and stenting is an
importantmodality of treatment in the subset of patients with
membranous obstruction of IVC. Angioplasty alone has high
recurrence rates due to elastic recoil. Hence, stent placement
in IVC after balloon angioplasty is recommended. Angioplasty
and stenting may be technically challenging when a thick
membrane is encountered as in our case. In such cases, using
Brokenborough’s needle is a safe and effective way of
increasing the success rates of the procedure as demonstrated.
Zhang et al reported the long term effects of stent place-
ment in IVC or hepatic veins in 115 patients. In this study
96.7% of IVC stents remained patent over a mean follow up of
49months. Absence of anticoagulants after the procedurewas
associated with higher incidence of stent occlusion.7 In
another study by Srinivas BC et al, twelve cases of hepatic vein
outflow obstruction who underwent endovascular balloon
dilatation stentingwere followed up for upto 13 years. There
was only one case of restenosis.8 Thus, endovascular man-
agement of IVC obstruction has long term patency rates.
In BCS with membranous obstruction of IVC, PTA and
stenting should be the treatment of choice as it can beaccomplished with least morbidity and mortality and excel-
lent long term patency rates.Conflicts of interest
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